HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 3, 1997, Pages 238-242

  De Carvalho, Silvia Maia Parias ^a,b   Pombo De Oliveira, Maria S ^a   Santos Thuler, Luiz Claudio ^a   Rios, Maria ^c   Coelho, Rita Cleide A ^b   Rubim, Luiz Carlos ^b   Silva, Evelyne Monteiro ^b   Reis, Ana Maria ^b   Catovsky, Daniel ^d  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Instituto Estadual de Hematologia   (Brazil)

^c NEW YORK BLOOD CENTER   (United States)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

HTLV infections in Brazil; HTLV I and HTLV II infections in hematologic patients

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BRAZIL; CANCER PATIENT; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; PRIORITY JOURNAL; SEROPREVALENCE; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS INFECTION;

HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 12644296010     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199707010-00008     Document Type: Article

References (28)

1. Blattner WA. Epidemiology of HTLV-I and associated diseases. In: Blattner WA (ed). Human retrovirology: HTLV. New York: Raven Press, 1990:251-65.
2. Levine PH. Jaffe ES, Manns A, Murphy EL, Clark J, Blattner WA. Human T-cell leukemia virus type I and adult T-cell leukemia/ lymphoma outside Japan and the Caribbean Basin. Yale J Biol Med 1988;61:215-222.
3. Kitagawa T, Fujishita M, Taguchi H, Miyoshi I Tadokoro H. Antibodies to HTLV-I in Japanese immigrants in Brazil. JAMA 1986; 256:2342.
4. Ferreira O, Vaz RS, Carvalho MB, et al. Human T-lymphotropic virus type I and II infections and correlation with risk factors in blood donors from São Paulo, Brazil. Transfusion 1995;35:258-63.
5. Cortes E, Detels R, Aboulafia D, et al. HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Brazil. N Engl J Med 1989;320;953-8.
6. Matutes E, Schulz T. Andrada Serpa MJ, Campos-Araujo AQ, Pombo de Oliveira MS. Report of the Second International Symposium on HTLV in Brazil. Leukemia 1994;8:1092-4.
7. Maloney EM, Biggar RJ, Neel JV, et al. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992;166:100-7.
8. Nakauchi CM, Maryama K, Kanzaki LI, et al. Prevalence of HTLV-I antibody among two distinct ethnic groups inhabiting the Amazon region of Brazil. Rev Inst Med Trop Sao Paulo 1992;34: 323-8.
9. Ishak R, Harrington WJ, Azevedo VN, et al. Identification of human T-cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-21.
10. Eiraku N, Novoa P, Ferreira MC, et al. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2. J Virol 1996;70:1481-92.
11. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of HTLV in all primary tumors of adult T-cell leukemia suggests causative role of HTLV in the disease. Proc Natl Acad Sci USA 1984;81:2534-7.
12. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
13. Franchini G. Molecular mechanisms of human T-cell leukemia/ lymphoma virus type I infection. Blood 1995;86:3619-39.
14. Catovsky D, Foa R. The lymphoid leukemias. London: Butterworths, 1990.
15. Rios M, Kabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C. Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I screened blood products. J Infect Dis 1994;170:206-10.
16. Pombo de Oliveira MS, Matutes E, Schulz T, et al. T-cell malignancies in Brazil. Clinicopathological and molecular studies of HTLV-I positive and negative cases. Int J Cancer 1995;68:823-7.
17. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981:14-15.
18. Takayanaqui OM, Cantos JL, Jardim E. Tropical spastic paraparesis in Brazil (letter). Lancet 1991;2:309.
19. Araujo AQC, Ali A, Newell A, Dagleish AG, Rudge P. HTLV-I infection and neurological disease in Rio de Janeiro. J Neurol Neurosurg Psychiatry 1992;55:153-5.
20. Moreira ED, Ribeiro TP, Swanson P, et al. Seroepidemiology of human T-cell lymphotropic virus type I/II in Northeastern Brazil. J Acquir Immune Defic Syndr 1993;6:959-63.
21. Proietti FA, Lima-Martins MVC, Passos VMA, Brener E, Carneiro-Proietti ABF. HTLV-I/I1 seropositivity among eligible blood donors from Minas Gerais State, Brazil [letter]. Vox Sang 1994; 67:77.
22. Gabbai AA, Bordini JO, Vieira-Filho JPB, et al. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg 1993;49:664-71.
23. Tajima K, Tominaga S, Suchi T. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia virus associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Jpn J Cancer Res 1982;73:893-901.
24. Murphy E. The epidemiology of HTLV-I: modes of transmission and their relation to patterns of seroprevalence. In Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990:295-305.
25. Osame M, Izumo S, Igata A. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986;2:104-5.
26. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-8.
27. Manns A, Murphy EL, Wilks R, et al. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood 1991;77:896-901.
28. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992;51:886-91.